Stocksigma LogoStocksigma Logo

Genomic Valley Biotech Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR)

■ Revenue: 3,80,000 (-57.8% YoY | +1.3% QoQ) ■ EBITDA: 1,54,162 (-39.4% YoY | +437.4% QoQ) ■ EBITDA Margin (%): 40.6 (+1229 bps YoY | +3292 bps QoQ) ■ PAT

Genomic Valley Biotech Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR)

Genomic Valley Biotech Ltd · Financial Result · 14 Aug 2026, 10:05 pm

Genomic Valley Biotech Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR) ■ Revenue: 3,80,000 (-57.8% YoY | +1.3% QoQ) ■ EBITDA: 1,54,162 (-39.4% YoY | +437.4% QoQ) ■ EBITDA Margin (%): 40.6 (+1229 bps YoY | +3292 bps QoQ) ■ PAT: 1,46,162 (-40.7% YoY | Loss to Profit QoQ) ■ EPS (INR): 0.05 (-37.5% YoY | Loss to Profit QoQ)

Original exchange filing (PDF)

More announcements from Genomic Valley Biotech Ltd

All Genomic Valley Biotech Ltd announcements